Form 4: Masimo Corporation Acquired by Danaher for $180 Per Share

Masimo Corporation has completed its merger with Danaher Corporation, resulting in the cancellation of all outstanding common stock and equity awards.

Summary

• Masimo Corporation was acquired by Danaher Corporation on June 10, 2026.
• All outstanding shares of Masimo common stock were converted into the right to receive $180.00 per share in cash.
• Outstanding restricted stock units (RSUs) were assumed by Danaher and converted into Danaher RSU equivalents.
• Outstanding stock options were canceled and converted into a cash payment representing the difference between the $180 merger price and the option exercise price.
• Anand Sampath, EVP of Operations, reported the disposition of 33,901 shares and various derivative holdings as a result of the merger.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the final administrative step of a previously announced merger rather than new operational performance.

Positives

• Shareholders received a cash consideration of $180.00 per share.
• Successful completion of the merger agreement dated February 16, 2026.

Negatives

• Masimo Corporation ceases to be an independent publicly traded entity.
• Equity holders no longer hold direct ownership in Masimo Corporation.

Risks

• Integration risks associated with becoming a wholly owned subsidiary of Danaher Corporation.

Future Outlook

Masimo Corporation now operates as a wholly owned subsidiary of Danaher Corporation; no further independent guidance is provided.

Management Comments

• The transaction was executed pursuant to the Agreement and Plan of Merger dated February 16, 2026.

Industry Context

StockSavvy.ai notes that this acquisition represents a significant consolidation in the medical technology sector, with Danaher expanding its portfolio through the absorption of Masimo's monitoring and sensor technologies.

Comparison to Industry Standards

• The $180 per share cash-out price reflects the valuation agreed upon by the boards of both companies during the February 2026 negotiation period.
• The treatment of equity awards (RSUs and options) follows standard M&A protocols for cash-out and conversion in public company acquisitions.

Legal Proceedings

• The merger was completed pursuant to the Agreement and Plan of Merger dated February 16, 2026.

Stakeholder Impact

• Shareholders receive cash proceeds for their holdings.
• Employees and management transition to Danaher Corporation oversight.

Next Steps

• Delisting of Masimo Corporation from public stock exchanges.
• Integration of Masimo operations into Danaher Corporation.

Key Dates

Keywords

Masimo, Danaher, Merger, Acquisition, Form 4, SEC, Equity